Physician
Infectious Disease
Dr. Dimitrios P. Kontoyiannis, MD
|
|
Give Review
Dimitrios Kontoyiannis practices Infectious Disease. He went to Baylor College of Medicine. Doctor Dimitrios P. Kontoyiannis, MD is a published MD. He has 98 papers published. The most current publication "Mucormycoses." He is registered with Medicare.
Publications
- Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.
- Mucormycoses.
- Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.
- Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests.
- Evidence-based focused review of primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.
- T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.
- Methylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum.
- Emerging Issues With Diagnosis and Management of Fungal Infections in Solid Organ Transplant Recipients.
- Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.
- Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious...
- Development of new strategies for early diagnosis of mucormycosis from bench to bedside.
- A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.
- Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention.
- Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.
- Switching from Posaconazole Suspension to Tablets Increases Serum Drug Levels in Leukemia Patients without Clinically Relevant Hepatotoxicity.
- Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
- Reply to "Detection of Multiple Fungal Species in Blood Samples by Real-Time PCR: an Interpretative Challenge".
- Reply to "Not Over Yet: Fungal Infections following Methyl Prednisolone Injections Smoulder On".
- Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis.
- Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.
- Efficacy and Tolerability of Micafungin Monotherapy for Candidemia and Deep-Seated Candidiasis in Adults with Cancer.
- Dimorphic fungal osteoarticular infections.
- Phenotypic Differences of Cryptococcus Molecular Types: implications for virulence in a Drosophila model of infection.
- Methylprednisolone Enhances the Growth of Exserohilum rostratum In-Vitro, Attenuates Spontaneous Apoptosis, and Increases Mortality Rates in Immunocompetent Drosophila...
- Co-infection with Influenza: Do Not Forget Aspergillus in the Immunosuppressed Neutropenic Host.
- Fungal DNA Detected from Blood of Patients Who Received Contaminated Methylprednisolone Injections reveals more complexity of causative agents.
- Effectiveness of Primary anti-Aspergillus Prophylaxis During Remission Induction Chemotherapy of Acute Myeloid Leukemia.
- Disseminated Saprochaete capitata (formerly known as Geotrichum capitatum, and Blastoschizomyces capitatus) in a patient with acute myeloid leukemia.
- Are respiratory complications more likely in patients with pulmonary aspergillosis treated with echinocandins in the setting of neutrophil influx?
- Macrophage Reporter Cell Assay for Screening Immunopharmacological Activity of Cell-Wall Active Antifungals.
- Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers.
- Update on mucormycosis pathogenesis.
- Aspergillus osteomyelitis: Epidemiology, clinical manifestations, management, and outcome.
- Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia in a Tertiary Cancer Center, 2009 - 2011.
- Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.
- The diagnostic yield of skin biopsy in patients with leukemia and suspected infection.
- Aspergillus fumigatus Hyphal Damage Caused by Noninvasive Radiofrequency Field-Induced Hyperthermia.
- Hyperthermia Sensitizes Rhizopus oryzae to Posaconazole and Itraconazole Action through Apoptosis.
- The impact of infectious diseases consultation on oncology practice.
- The Calcineurin Pathway Inhibitor Tacrolimus Enhances The In Vitro Activity Of Azoles Against Mucorales Via Apoptosis.
- Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis.
- Paradoxical effect to caspofungin in Candida species does not confer survival advantage in a Drosophila model of candidiasis.
- What Can We Learn and What Do We Need to Know Amidst the Iatrogenic Outbreak of Exserohilum Rostratum Meningitis?
- Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study.
- Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
- Real-time Treatment Guidelines: Considerations During the Exserohilum rostratum Outbreak in the United States.
- Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.
- Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germinati...
- Tacrolimus Enhances the Potency of Posaconazole Against Rhizopus oryzae In vitro and In an Experimental Models of Mucormycosis.
- The Safety of Amphotericin B Lipid Complex in Patients With Prior Severe Intolerance to Liposomal Amphotericin B.
- The impact of azole resistance on aspergillosis guidelines.
- Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?
- Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).
- Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37.
- Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most co...
- Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.
- Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: A retrospective multicenter study.
- Invasive mycoses: strategies for effective management.
- Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies.
- Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.
- Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity).
- Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
- The power of a legend.
- The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.
- Central Venous Catheter-associated Nocardia Bacteremia in Cancer Patients.
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance.
- Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.
- Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
- Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients.
- In vitro susceptibility of Aspergillus to echinocandins: Isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.
- Outcome Analysis of Invasive Aspergillosis in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients: The Role of Novel Antimold Azoles.
- Fungal pneumonia in patients with hematologic malignancies: current approach and management.
- How I treat mucormycosis.
- Are serum cytokines sensitive and specific enough to prognosticate in aspergillosis?
- Efficacy of Caspofungin in Neutropenic and Corticosteroid-Immunosuppressed Murine Models of Invasive Pulmonary Mucormycosis.
- Deferasirox lacks in vitro activity against Fusarium and Scedosporium species and black molds.
- The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.
- Drosophila melanogaster as a Model Host for the Study of Microbial Pathogenicity and the Discovery of Novel Antimicrobial Compounds.
- Mucormycosis caused by unusual mucormycetes, non-rhizopus, -mucor, and -lichtheimia species.
- Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents.
- Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement.
- Fungal infections in transplant and oncology patients.
- Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: A Prospective 2-Year Study.
- Activity of deferasirox in Mucorales: influences of species and exogenous iron.
- Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): Diverse and impactful.
- New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients.
- The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment.
- Toll-deficient Drosophila are resistant to infection by Pneumocystis spp.: additional evidence of specificity to mammalian hosts.
- Breast implant infections: is cefazolin enough?
- Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.
- Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation.
- Factors associated with mortality in transplant patients with invasive aspergillosis.
- Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines.
- Manipulation of host angioneogenesis: A critical link for understanding the pathogenesis of invasive mold infections?
- Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant.
- Cutaneous model of invasive aspergillosis.
- Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Su...
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Massachusetts General Hospital -
Baylor College of Medicine -
University of Athens
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1649376476 | |
| NPPES Provider LastName | KONTOYIANNIS | |
| NPPES Provider FirstName | DIMITRIOS | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 104.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649376476 |
| Last Name Of The Provider | KONTOYIANNIS |
| First Name Of The Provider | DIMITRIOS |
| View All |
Similar Doctors
|
|
Dr. Victor E. Mulanovich, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Chou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ben J. Barnett, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William P. Goins, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Husam I. Issa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madiha Ashraf, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Maria E. Carlini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick J. Buckwold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto C. Arduino, MD
This Doctor is OpenDoctor Recommended.
|